Remove 2019 Remove Consumer Goods Remove Pharmaceutical
article thumbnail

U.S. automotive industry increased robot installations by 10% in 2024

Robotics Business Review

Already, these manufacturers produce robots for a huge domestic market that more than tripled from 2019 to 2023. A3 identified food and consumer goods, life sciences, pharmaceuticals, and biomedical as some of the fastest-growing industries in the U.S. This puts them in second place after Japan. for robotics.

article thumbnail

Additive Manufacturing Growth: Review of 2022 Collaborations, Acquisitions, and Funding

Additive Manufacturing

TIWARI Scientific Instruments was created in 2019 within the ESA (European Space Agency) ecosystem. Triastek and Siemens Announce Strategic Collaboration to Accelerate Digital Transformation of the Pharmaceutical Industry : Triastek, Inc. and Siemens Ltd.,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Automated Grinding Machines Yield Tighter Tolerances and Save Resources

Mold Making Technology

On the mold base side, National services customers within industries such as medical, consumer goods, automotive, packaging and pharmaceuticals. In particular, the packaging and pharmaceutical customers require tight tolerances due to molded material type, volume and critical dimensioning.

article thumbnail

Back In Action: An MCMT Special

Dinesh Mishra

In addition to this, high demand in the consumer goods industry leads to high demand in the Die & Mould segment. Other segments like defense, railways, and capital goods industry also are contributing in a good way to the overall demand. Medical plastics deliver a pharmaceutical compound to its target site.

article thumbnail

Top Legal Issues Facing the Manufacturing Sector in 2023

Foley

Healthcare and Pharmaceuticals. When it comes to healthcare and pharmaceuticals, cyberattacks can have particularly dire consequences. 2019) (rejecting defendant’s argument that no duty to report arose because “none of the reported injuries rose to any particular level of seriousness”). § 2064(b).